Changes in renal, bone, lipid, and inflammation markers in HIV-1 patients after combination antiretroviral therapy simplification to dolutegravir monotherapy

Autor: M. C. Zillikens, Ingeborg E A Wijting, Eric C. M. van Gorp, Casper Rokx, Marchina E. van der Ende, Jan L. Nouwen, Annelies Verbon, Sandra A. A. Smits, Wouter F W Bierman, Carolina A. M. Schurink, Theodora E. M. S. de Vries-Sluijs, Hannelore I. Bax, Bart J. A. Rijnders

Publikováno v: International Journal of STD & AIDS, 30(11), 1042-1048. SAGE Publications Inc.
International Journal of Std & Aids, 30(11), 1042-1048. SAGE Publications Ltd

Combination antiretroviral therapy (cART) can cause metabolic toxicities. How cART simplification to dual or monotherapies affects metabolic markers is unknown. We analyzed the metabolic effects of cART simplification to dolutegravir (DTG) monotherap

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff2d86a1773c1fa1c39ca65f06fc8a8d
https://research.rug.nl/en/publications/b92c0516-0a0a-4fb7-9599-d834018a76dc